SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-13-036266
Filing Date
2013-05-02
Accepted
2013-05-02 08:36:03
Documents
3
Period of Report
2013-05-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a13-8304_38k.htm 8-K 22180
2 EX-99.1 a13-8304_3ex99d1.htm EX-99.1 96049
3 GRAPHIC g83043mmi001.jpg GRAPHIC 3870
  Complete submission text file 0001104659-13-036266.txt   125002
Mailing Address 119 FOURTH AVE NEEDHAM MA 02494-2725
Business Address 119 FOURTH AVE NEEDHAM MA 02494 7814330771
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-15006 | Film No.: 13805529
SIC: 2835 In Vitro & In Vivo Diagnostic Substances